FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare

Free Newsletter

About | View Sample | Privacy

Roche confident of Genentech success

Tools

Roche posted lower profits than expected yesterday and executives took a cautious stance on future earnings, but they insist that their new, lower bid for Genentech will win over shareholders. "We are confident shareholders will consider this fair," said CEO Severin Schwan (photo). "We are not buying shares and we have no discussions on that point with the shareholders." Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:
Be the first to comment
More stories about Mergers and Acquisitions   Genentech   Severin Schwan   Roche  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.